Istituto Europeo di Oncologia
Milan, Mi, 20141, Italy
Location status: Recruiting
NCT Number: NCT07790406
Early-stage lung cancer represents a clinical challenge that, when diagnosed promptly, offers high chances of cure through lobectomy and lymphadenectomy. In addition to traditional surgery, robotic techniques have become established and have recently evolved further with the Single-Port system, which allows the procedure to be performed through a single subcostal incision rather than multiple openings between the ribs. This approach reduces invasiveness, postoperative pain, and recovery time, while maintaining the same oncological effectiveness and safety as standard techniques. This is a monocentric and non-profit collection of clinical data, both prospective and retrospective, from patients treated with this method, ensuring data privacy through coded information and compliance with current regulations; the study is independent and non-profit.
Interested in participating?
Request InfoAll sexes
Observational
Milan, Mi, 20141, Italy
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
U-RATS lobectomy
Time frame: "From enrollment to the end of 5 year follow-up
The objective of this study is to collect and describe IEO experiences in the use of the Da Vinci SP surgical system for anatomical lung resection.
Contact information is provided by the study sponsor or research team.
European Institute of Oncology
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06987890
Bronchial Neoplasms, Carcinoma, Bronchogenic
Boston, Massachusetts, United States
View Trial DetailsNCT07783971
Bacterial Infections and Mycoses, Bronchial Neoplasms
Chongqing, Liangjiang New, China
View Trial DetailsNCT07777822
Bronchial Neoplasms, Carcinoma, Bronchogenic
Plantation, Florida, United States
View Trial DetailsNCT07489066
Bronchial Neoplasms, Carcinoma
Hinsdale, Illinois, United States
View Trial Details